Trial Profile
Combination therapy with infliximab and thiopurine compared to infliximab monotherapy in maintaining remission of postoperative Crohn's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 02 Feb 2016 New trial record